Anthropometric and biochemical correlates of PAPP-A2, free IGF-I, and IGFBP-3 in childhood.


Journal

European journal of endocrinology
ISSN: 1479-683X
Titre abrégé: Eur J Endocrinol
Pays: England
ID NLM: 9423848

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 23 10 2019
accepted: 21 01 2020
pubmed: 22 1 2020
medline: 25 2 2020
entrez: 22 1 2020
Statut: ppublish

Résumé

Pregnancy-associated plasma protein-A2 (PAPP-A2) is a metalloproteinase that cleaves IGFBP-3 and IGFBP-5. Human mutations in PAPPA2 result in short stature with a low percentage of free IGF-I. Little is known about PAPP-A2 levels and the regulation of free IGF-I throughout childhood. We examined PAPP-A2 and intact IGFBP-3 levels in childhood and explored associations between PAPP-A2, free and total IGF-I, and total and intact IGFBP-3 and their relationship to the percentage of free to total IGF-I and anthropometric factors. Cross-sectional study at a single center. PAPP-A2, free IGF-I, and intact IGFBP-3 levels were measured in childhood (3-18 years old) and an evaluation of the relationship between these proteins and anthropometric factors. In 838 children, PAPP-A2 consistently decreased throughout childhood. In contrast, free IGF-I increased. A pubertal peak in free IGF-I was present in females but was less evident in males. Intact and total IGFBP-3 increased throughout childhood; however, intact IGFBP-3 had a more marked rise than total IGFBP-3. Percent free IGF-I decreased with no distinct pubertal peak. PAPP-A2 levels positively correlated with the percent free IGF-I (Male, Female; r = 0.18, 0.38; P < 0.001) and negatively with intact IGFBP-3 (Male, Female; r = -0.58, -0.65; P < 0.0001). This is the first study to describe serum PAPP-A2 and intact IGFBP-3 in children between 3 and 18 years of age. Our correlative findings suggest that PAPP-A2 is an important regulator of the percent free IGF-I which can be a marker of perturbations in the GH/IGF-I axis.

Identifiants

pubmed: 31961798
doi: 10.1530/EJE-19-0859
pii: EJE-19-0859.R1
pmc: PMC7238294
mid: NIHMS1583389
doi:
pii:

Substances chimiques

IGF1 protein, human 0
IGFBP3 protein, human 0
Insulin-Like Growth Factor Binding Protein 3 0
Insulin-Like Growth Factor I 67763-96-6
PAPPA2 protein, human EC 3.4.-
Pregnancy-Associated Plasma Protein-A EC 3.4.24.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

363-374

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD078592
Pays : United States

Références

PLoS One. 2011;6(8):e23714
pubmed: 21912604
J Clin Endocrinol Metab. 1997 Jan;82(1):156-8
pubmed: 8989251
J Cell Commun Signal. 2015 Jun;9(2):177-87
pubmed: 25617049
J Biol Chem. 2001 Jun 15;276(24):21849-53
pubmed: 11264294
J Endocrinol. 2009 Sep;202(3):337-45
pubmed: 19474058
Adv Data. 2000 Jun 8;(314):1-27
pubmed: 11183293
J Clin Endocrinol Metab. 2014 May;99(5):1712-21
pubmed: 24606072
J Clin Endocrinol Metab. 1997 Aug;82(8):2497-502
pubmed: 9253324
Eur J Endocrinol. 1996 Feb;134(2):184-9
pubmed: 8630517
Clin Biochem. 2012 Jan;45(1-2):16-21
pubmed: 22032863
J Clin Endocrinol Metab. 1995 Nov;80(11):3284-6
pubmed: 7593439
Int J Pediatr Endocrinol. 2013 Feb 13;2013(1):6
pubmed: 23406437
J Mol Endocrinol. 2018 Jul;61(1):T69-T86
pubmed: 29535161
J Clin Endocrinol Metab. 1994 Mar;78(3):744-52
pubmed: 8126152
Front Endocrinol (Lausanne). 2011 Dec 12;2:95
pubmed: 22654835
J Clin Endocrinol Metab. 2008 Nov;93(11):4210-7
pubmed: 18782877
Sci Rep. 2017 Sep 5;7(1):10455
pubmed: 28874827
Am J Physiol Endocrinol Metab. 2000 Jun;278(6):E967-76
pubmed: 10826997
Endocrinol Jpn. 1992 Dec;39(6):585-91
pubmed: 1284115
Metabolism. 1995 Oct;44(10 Suppl 4):37-44
pubmed: 7476310
J Clin Endocrinol Metab. 2014 May;99(5):1675-86
pubmed: 24483154
J Mol Endocrinol. 2018 Jul;61(1):T11-T28
pubmed: 29255001
EMBO Mol Med. 2016 Mar 31;8(4):363-74
pubmed: 26902202
J Clin Endocrinol Metab. 2005 Nov;90(11):6028-34
pubmed: 16091488
Horm Res. 2001;55(3):115-24
pubmed: 11549872
Clin Pediatr Endocrinol. 2004;13(1):71-8
pubmed: 24790301
Curr Opin Endocrinol Diabetes Obes. 2012 Feb;19(1):47-52
pubmed: 22157400
Genomics. 2015 Jul;106(1):15-22
pubmed: 25817197
Mol Hum Reprod. 2013 Nov;19(11):756-63
pubmed: 23804707
J Pediatr. 2005 Jun;146(6):751-8
pubmed: 15973311
Natl Health Stat Report. 2013 Feb 11;(63):1-3
pubmed: 24992748
Mol Endocrinol. 1997 Jun;11(7):997-1007
pubmed: 9178759
J Clin Endocrinol Metab. 2017 Dec 1;102(12):4568-4577
pubmed: 29029190
J Clin Endocrinol Metab. 1999 Jan;84(1):82-9
pubmed: 9920066
PLoS One. 2011 Feb 28;6(2):e16522
pubmed: 21387019
J Clin Endocrinol Metab. 2009 Aug;94(8):3093-7
pubmed: 19470623
J Mol Endocrinol. 2018 Jul;61(1):T139-T169
pubmed: 29563157
J Clin Endocrinol Metab. 2014 Oct;99(10):E1988-96
pubmed: 24926947
Endocr Rev. 2011 Aug;32(4):472-97
pubmed: 21525302
J Clin Endocrinol Metab. 2000 Nov;85(11):4162-7
pubmed: 11095448
Endocr J. 2012;59(9):771-80
pubmed: 22673406
Horm Res Paediatr. 2016;86(6):361-397
pubmed: 27884013

Auteurs

Masanobu Fujimoto (M)

Cincinnati Center for Growth Disorders, Division of Endocrinology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Division of Pediatrics and Perinatology, Tottori University Faculty of Medicine, Yonago, Japan.

Jane C Khoury (JC)

Cincinnati Center for Growth Disorders, Division of Endocrinology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

Philip R Khoury (PR)

Heart Institute Research Core, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

Bhanu Kalra (B)

Ansh Labs, Webster, Texas, USA.

Ajay Kumar (A)

Ansh Labs, Webster, Texas, USA.

Patrick Sluss (P)

Ansh Labs, Webster, Texas, USA.

Claus Oxvig (C)

Department of Molecular Biology and Genetics, Aarhus University, Aarhus C, Denmark.

Vivian Hwa (V)

Cincinnati Center for Growth Disorders, Division of Endocrinology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

Andrew Dauber (A)

Cincinnati Center for Growth Disorders, Division of Endocrinology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Division of Endocrinology, Children's National Hospital, Washington, District of Columbia, USA.
Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH